Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation

Trials

Kris Vanhaecht¹  Svin Deneckere³  Massimiliano Panella²  Walter Sermeus³  Marc Decramer⁴  Cathy Lodewijckx³ 

[1] Western Norway Research Network on Integrated Care, Helse Fonna, Haugesund, Norway;Department of Public Health, Department of Clinical and Experimental Medicine, Faculty of Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;European Pathway Association, Kapucijnenvoer, Leuven, Belgium;Faculty of Medicine, KU Leuven University of Leuven, Leuven, Belgium

关键词: Chronic obstructive pulmonary disease;    Cluster randomized trial;    Standardization;    Evidence based medicine;    Critical pathway;   

Others  :  1095109
DOI  :  10.1186/1745-6215-13-229

 received in 2012-05-20, accepted in 2012-10-23,  发布年份 2012

【 摘 要 】

Background

Optimization of the clinical care process by integration of evidence-based knowledge is one of the active components in care pathways. When studying the impact of a care pathway by using a cluster-randomized design, standardization of the care pathway intervention is crucial. This methodology paper describes the development of the clinical content of an evidence-based care pathway for in-hospital management of chronic obstructive pulmonary disease (COPD) exacerbation in the context of a cluster-randomized controlled trial (cRCT) on care pathway effectiveness.

Methods

The clinical content of a care pathway for COPD exacerbation was developed based on recognized process design and guideline development methods. Subsequently, based on the COPD case study, a generalized eight-step method was designed to support the development of the clinical content of an evidence-based care pathway.

Results

A set of 38 evidence-based key interventions and a set of 24 process and 15 outcome indicators were developed in eight different steps. Nine Belgian multidisciplinary teams piloted both the set of key interventions and indicators. The key intervention set was judged by the teams as being valid and clinically applicable.In addition, the pilot study showed that the indicators were feasible for the involved clinicians and patients.

Conclusions

The set of 38 key interventions and the set of process and outcome indicators were found to be appropriate for the development and standardization of the clinical content of the COPD care pathway in the context of a cRCT on pathway effectiveness. The developed eight-step method may facilitate multidisciplinary teams caring for other patient populations in designing the clinical content of their future care pathways.

【 授权许可】

   
2012 Lodewijckx et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Institute of Medicine: Creating safety systems in health care organisations. In To Err is Human: Building a Safer Health System. Washington: National Academy Press; 2000:155-201.
• [2]Grol R, Grimshaw J: From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003, 362:1225-1230.
• [3]Grol R, Wensing M: What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust 2004, 180:S57-S60.
• [4]Institute of Medicine: Applying evidence to health care delivery. In Crossing the Quality Chasm. Washington, DC 20418: National Academy Press; 2001:145-163.
• [5]Lodewijckx C, Sermeus W, Vanhaecht K, Panella M, Deneckere S, Leigheb F, Decramer M: Inhospital management of COPD exacerbations: a systematic review of the literature with regard to adherence to international guidelines. J Eval Clin Pract 2009, 15:1101-1110.
• [6]Campbell H, Hotchkiss R, Bradshaw N, Porteous M: Integrated care pathways. BMJ 1998, 316:133-137.
• [7]Pearson SD, Goulart-Fisher D, Lee TH: Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med 1995, 123:941-948.
• [8]Vanhaecht K, De Witte K, Sermeus W: The Care Process Organisation Triangle: a framework to better understand how clinical pathways work. Int J Care Pathw 2007, 11:1-8.
• [9]Vanhaecht K, Sermeus W, Peers J, Lodewijckx C, Deneckere S, Leigheb F, Decramer M, Panella M, for the EQCP Study Group: The impact of care pathways for exacerbation of chronic obstructive pulmonary disease: rationale and design of a cluster randomized controlled trial. Trials 2010, 11:111. BioMed Central Full Text
• [10]Medical Research Council: Developing and evaluating complex interventions: new guidance. http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC004871 webcite
• [11]Sermeus W, De Bleser L, Depreitere R, Dewaele K, Vanhaecht K, Vlayen J: An introduction to clinical pathways. In KCE Reports Volume 18A: The Use of Clinical Pathways and Guidelines to Determine Physicians' Hospital Fees Prospectively: Easier Said Than Done. Edited by Devriese S, Lambert M, Eyssen M, Sande S, Poelmans J, Brabandt H, Sermeus W, Vlayen J, Ramaekers D. Brussels: Belgian Healthcare Knowledge Centre (KCE); 2005:34-44. http://www.kenniscentrum.fgov.be/nl/publicaties.html webcite
• [12]Medical Research Council: Cluster Randomized Trials: Methodological and Ethical Considerations. http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC002406 webcite
• [13]Oakley A, Strange V, Bonell C, Allen E, Stephenson J: Process evaluation in randomised controlled trials of complex interventions. BMJ 2006, 332:413-416.
• [14]Vanhaecht K, Ovretveit J, Elliott MJ, Sermeus W, Ellershaw J, Panella M: Have we drawn the wrong conclusions about the value of care pathways? Is a Cochrane review appropriate? Eval Health Prof 2012, 35:28-42.
• [15]Hawe P, Shiell A, Riley T: Complex interventions: how "out of control" can a randomised controlled trial be? BMJ 2004, 328:1561-1563.
• [16]Berry SA, Doll MC, McKinley KE, Casale AS, Bothe A Jr: ProvenCare: quality improvement model for designing highly reliable care in cardiac surgery. Qual Saf Health Care 2009, 18:360-368.
• [17]Schunemann HJ, Cook D, Guyatt G: Methodology for antithrombotic and thrombolytic therapy guideline development: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest 2008, 133:113S-22S.
• [18]Schunemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L, Wisloff TF, Del Mar C, Hayden F, Uyeki TM, Farrar J, Yazdanpanah Y, Zucker H, Beigel J, Chotpitayasunondh T, Hien TT, Ozbay B, Sugaya N, Oxman AD: Transparent development of the WHO rapid advice guidelines. PLoS Med 2007, 4:e119.
• [19]Umscheid CA, Agarwal RK, Brennan PJ: Updating the guideline development methodology of the Healthcare Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 2010, 38:264-273.
• [20]Goldmann D: Five puzzle pieces, ten cautionary notes. Int J Care Pathw 2010, 14:33-35.
• [21]Vanhaecht K, Deneckere S, Van Gerven E, Lodewijckx C, Janssens I, Van Zelm R, Boto P, Panella M, Biringer E, Sermeus W: The 7-phase method to design, implement and evaluate care pathways. Int J Pers Cent Med 2012, 2:341-351.
• [22]NHS Centre for Reviews and Dissemination (CRD): Systematic Reviews: CRD’s guidance for undertaking reviews in health care. 2009. http://www.york.ac.uk/inst/crd/pdf/Systematic_Reviews.pdf webcite
• [23]Anzueto A, Sethi S, Martinez FJ: Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007, 4:554-564.
• [24]BMJ: Acute Exacerbation of Chronic Obstructive Pulmonary Disease. http://bestpractice.bmj.com/best-practice/monograph/8.html webcite
• [25]Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Mölken MP, Stockley R, Sullivan SD, Wedzicha JA, Wouters EF, American Thoracic Society; European Respiratory Society Task Force on outcomes of COPD: Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008, 31:416-469.
• [26]Evensen A: Management of COPD exacerbations. Am Fam Physician 2010, 81:607-613.
• [27]Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention Of Chronic Obstructive Pulmonary Disease. Revised 2011. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011Dec30.pdf webcite
• [28]Glaab T, Vogelmeier C, Buhl R: Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res 2010, 11:79. BioMed Central Full Text
• [29]Hurst JR, Wedzicha JA: Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review. BMC Med 2009, 7:40. BioMed Central Full Text
• [30]Kunisaki KM, Rice KL, Niewoehner DE: Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: an appraisal of published evidence. Drugs Aging 2007, 24:303-324.
• [31]Map of Medicine: Specialist Management of Acute Exacerbation. 2012. http://www.mapofmedicine.com webcite
• [32]National Institute for Health and Clinical Excellence (NICE): Chronic Obstructive Pulmonary Disease - Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. 2010. http://guidance.nice.org.uk/CG101 webcite
• [33]Osthoff M, Leuppi JD: Management of chronic obstructive pulmonary disease patients after hospitalization for acute exacerbation. Respiration 2010, 79:255-261.
• [34]Rabbat A, Guetta A, Lorut C, Lefebvre A, Roche N, Huchon G: [Management of acute exacerbations of COPD]. Rev Mal Respir 2010, 27:939-953.
• [35]Rodriguez-Roisin R: COPD exacerbations: management. Thorax 2006, 61:535-544.
• [36]Scullion J: Patient-focused outcomes in chronic obstructive pulmonary disease. Nurs Stand 2008, 22:50-56.
• [37]Siafkas N, Wedzicha J: Management of Chronic Obstructive Pulmonary Disease. Edited by Siafkas N. Sheffield: European Respiratory Society, Ltd; 2006:387-400.
• [38]Vogelmeier C, Buhl R, Criee CP, Gillissen A, Kardos P, Kohler D, Magnussen H, Morr H, Nowak D, Pfeiffer-Kascha D, Petro W, Rabe K, Schultz K, Sitter H, Teschler H, Welte T, Ettengel R, Worth H: Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft fur Pneumologie und Beatmungsmedizin. Pneumologie 2007, 61:e1-40.
• [39]Bahadori K, FitzGerald JM: Risk factors of hospitalization and readmission of patients with COPD exacerbation–systematic review. Int J Chron Obstruct Pulmon Dis 2007, 2:241-251.
• [40]Chenna PR, Mannino DM: Outcomes of severe COPD exacerbations requiring hospitalization. Semin Respir Crit Care Med 2010, 31:286-294.
• [41]Dal Negro R: Optimizing economic outcomes in the management of COPD. Int J Chron Obstruct Pulmon Dis 2008, 3:1-10.
• [42]Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP: Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009, 374:1171-1178.
• [43]Doll H, Miravitlles M: Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature. Pharmacoeconomics 2005, 23:345-363.
• [44]Effing T, Monninkhof EM, Van der Valk PD, Van der Palen J, Van Herwaarden CL, Partidge MR, Walters EH, Zielhuis GA: Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007, 4:CD002990.
• [45]Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, Omachi TA: Influence of anxiety on health outcomes in COPD. Thorax 2010, 65:229-234.
• [46]Gartlehner G, Hansen RA, Carson SS, Lohr KN: Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Ann Fam Med 2006, 4:253-262.
• [47]Hartman JE, Boezen HM, de Greef MH, Bossenbroek L, Ten Hacken NH: Consequences of physical inactivity in chronic obstructive pulmonary disease. Expert Rev Respir Med 2010, 4:735-745.
• [48]Lodewijckx C, Sermeus W, Vanhaecht K, Panella M, Deneckere S, Leigheb F, Decramer M: Impact of care pathways for in-hospital management of COPD exacerbations: a systematic review. Int J Nurs Stud 2011, 48:1445-1456.
• [49]Poole PJ, Chacko E, Wood-Baker RW, Cates CJ: Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, 1:CD002733.
• [50]Roche N, Rabbat A, Zureik M, Huchon G: Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome. Curr Opin Pulm Med 2010, 16:112-117.
• [51]Rotter T, Kinsman L, James E, Machotta A, Gothe H, Willis J, Snow P, Kugler J: Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev 2010, 3:CD006632.
• [52]Seemungal TA, Hurst JR, Wedzicha JA: Exacerbation rate, health status and mortality in COPD–a review of potential interventions. Int J Chron Obstruct Pulmon Dis 2009, 4:203-223.
• [53]Steer J, Gibson GJ, Bourke SC: Predicting outcomes following hospitalization for acute exacerbations of COPD. QJM 2010, 103:817-829.
• [54]Stockley RA, Whitehead PJ, Williams MK: Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis. Respir Res 2006, 7:147. BioMed Central Full Text
• [55]Van Wetering CR, Hoogendoorn M, Mol SJ, Rutten-van Molken MP, Schols AM: Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax 2010, 65:7-13.
• [56]Yohannes AM, Willgoss TG, Vestbo J: Tiotropium for treatment of sTable COPD: a meta-analysis of clinically relevant outcomes. Respir Care 2011, 56:477-487.
• [57]Campbell SM, Braspenning J, Hutchinson A, Marshall MN: Research methods used in developing and applying quality indicators in primary care. BMJ 2003, 326:816-819.
• [58]Hasson F, Keeney S, McKenna H: Research guidelines for the Delphi survey technique. J Adv Nurs 2000, 32:1008-1015.
• [59]Keeney S, Hasson F, McKenna H: Consulting the oracle: ten lessons from using the Delphi technique in nursing research. J Adv Nurs 2006, 53:205-212.
• [60]Lodewijckx C, Sermeus W, Panella M, Deneckere S, Leigheb F, Troosters T, Boto PAF, Mendez RV, Decramer M, Vanhaecht K: Quality indicators for in-hospital management of exacerbation of chronic obstructive pulmonary disease: results of an international Delphi study. J Adv Nurs 2012. Epub ahead of print
• [61]Siafkas N: Management of Chronic Obstructive Pulmonary Disease. Sheffield: European Respiratory Society, Ltd; 2006.
• [62]Atkins D, Best D, Briss PA, Eccles M, Famc-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schunemann HJ, Edejer TT, Varonen H, Vist GE, Williams JW Jr, Zaza S: Grading quality of evidence and strength of recommendations. BMJ 2004, 328:1490.
• [63]Scottish Intercollegiate Guidelines Network (SIGN): A Guideline Developer's Handbook: Annex B. http://www.sign.ac.uk/guidelines/fulltext/50/annexb.html webcite
• [64]Atkins D, Eccles M, Flottorp S, Guyatt GH, Harbour RT, Hill S, Jaeschke R, Liberati A, Magrini N, Mason J, O'Connell D, Oxman AD, Phillips B, Schunemann H, Edejer TT, Vist GE, Williams JW Jr: Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res 2004, 4:38. BioMed Central Full Text
• [65]Mainz J: Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003, 15:523-530.
• [66]Klimanthianaki M, Mitrouska I, Georgopoulos D: Management of end-stage chronic obstructive pulmonary disease. In Management of Chronic Obstructive Pulmonary Disease. Edited by Siafkas N. Sheffield: European Respiratory Journals Ltd; 2006:430-450.
• [67]Institute of Medicine: Improving the 21st-century health care system. In Crossing the Quality Chasm. DC 20418: National Academy Press, Washington; 2001:39-60.
• [68]Jaques H: Putting patients at the heart of quality. BMJ 2012, 344:e3164.
• [69]Vanhaecht K, Panella M, Van Zelm R, Sermeus W: Is there a future for care pathways? Five pieces to the puzzle. Intl J Care Pathw 2009, 13:82-86.
• [70]Fervers B, Carretier J, Bataillard A: Clinical practice guidelines. J Visc Surg 2010, 147:e341-e349.
• [71]Pierson DJ: Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources. Respir Care 2006, 51:277-288.
• [72]Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR: Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999, 282:1458-1465.
• [73]Pierson DJ: Translating evidence into practice. Respir Care 2009, 54:1386-1401.
• [74]Dixon-Woods M, Bosk CL, Aveling EL, Goeschel CA, Pronovost PJ: Explaining Michigan: developing an ex post theory of a quality improvement program. Milbank Q 2011, 89:167-205.
• [75]Panella M, Brambilla R, Marchisio S, Di Stanislao F: Reducing stroke in-hospital mortality: organized care is a complex intervention. Stroke 2008, 39:e186.